Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481531 · ClinicalTrials.gov registry record · NA
Growth and Tolerance of Cow's Milk-Based Infant Formulas
A NA study of Growth, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 373
- Enrollment target
- 20
- Study locations
NCT02481531: Completed NA study of Growth, sponsored by Mead Johnson Nutrition.
NCT02481531 is a NA study of Growth that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 373 participants, below the 624-participant average among 3 other Growth trials with a reported enrollment target (40% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02481531, a NA study of Growth, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 373 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.
Primary Outcome
Measurement collected with a calibrated infant scale
Conditions Studied
Interventions
- OTHER Previously marketed infant formula
- OTHER Previously marketed formula using a similar protein
Study Locations (20)
Ohio
- Pediatric Associates of Mt. Carmel, Inc - Cincinnati
- Ohio Pediatric Research Association - Dayton
- Pediatric Associates of Fairfield, Inc. - Fairfield
- UHMP Comprehensive Pediatrics - Westlake
Alabama
- Birmingham Pediatric Associates - Birmingham
- Southeastern Pediatric Associates - Dothan
- Pediatrics East - Alabama Clinical Therapeutics - Pinson
Kansas
- Heartland Research Associates, LLC - Augusta
- Heartland Research Associates, LLC - Newton
- Heartland Research Associates, LLC - Wichita
Arkansas
- Northwest Arkansas Pediatric Clinic - Fayetteville
- The Children's Clinic of Jonesboro, P.A. - Jonesboro
Kentucky
- Kentucky Pediatrics/Adult Research - Bardstown
- Owensboro Pediatrics - Owensboro
Connecticut
- Norwich Pediatric Group, P.C. - Norwich
Florida
- Children's Research, LLC - Altamonte Springs
Indiana
- Deaconess Clinical Research - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12-15 |
| Phase | NA |
What the finished NCT02481531 record still lists
NCT02481531 is an interventional study that assigns participants to a tested intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap, below the 624-participant average among 3 other Growth trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Growth appearing as the primary indexed condition, and to 2 interventions - of which Previously marketed infant formula is the first listed.
NCT02481531 names 20 study sites across 11 states, led by Ohio, Alabama, Kansas.
Frequently Asked Questions
What is clinical trial NCT02481531 about?
NCT02481531 is a clinical study titled "Growth and Tolerance of Cow's Milk-Based Infant Formulas". This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.
What is the current status of trial NCT02481531?
This trial is currently completed. It is a NA study. The enrollment target is 373 participants. The study started on 2015-07. Estimated completion is 2016-12-15.
What conditions does trial NCT02481531 study?
This clinical trial studies the following conditions: Growth.
What interventions are being tested in trial NCT02481531?
The interventions under investigation include: Previously marketed infant formula (OTHER), Previously marketed formula using a similar protein (OTHER).
Who is sponsoring clinical trial NCT02481531?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02481531 being conducted?
This trial has 20 study locations across Alabama, Arkansas, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07276750 · 373 participants · NA
Coaching and Leadership in Autism Support Settings
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia